Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Adami

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Calcified Tissue International|January 1, 1997
Effect of chronic treatment with ipriflavone in postmenopausal women with low bone massC Gennari, S Adami, D Agnusdei, et al.
Reumatismo|January 22, 2011
[Risk factors for hip fracture in elderly persons]M Rossini, A Mattarei, V Braga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisR Rizzoli, S L Greenspan, G Bone, et al.
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
Annals of the Rheumatic Diseases|December 13, 2005
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyJ-Y Reginster, S Adami, P Lakatos, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 25, 2006
Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year surveyP Piscitelli, G Iolascon, F Gimigliano, et al.
Clinical and Experimental Rheumatology|June 7, 2011
Baseline characteristics of the population enrolled in the Italian Observational Study on Severe Osteoporosis (ISSO)S Adami, D Maugeri, V Toscano, et al.
Reumatismo|February 10, 2010
[Guidelines for the diagnosis, prevention and treatment of osteoporosis]S Adami, F Bertoldo, M L Brandi, et al.
Aging (Milan, Italy)|April 4, 2000
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study GroupT Schnitzer, H G Bone, G Crepaldi, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Controlled trial of calcitriol in the prevention of bone disease in haemodialysed patientsV L Sharman, S M Abrams, S Adami, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Calcified Tissue International|January 1, 1997
Effect of chronic treatment with ipriflavone in postmenopausal women with low bone massC Gennari, S Adami, D Agnusdei, et al.
Reumatismo|January 22, 2011
[Risk factors for hip fracture in elderly persons]M Rossini, A Mattarei, V Braga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisR Rizzoli, S L Greenspan, G Bone, et al.
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
Annals of the Rheumatic Diseases|December 13, 2005
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyJ-Y Reginster, S Adami, P Lakatos, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 25, 2006
Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year surveyP Piscitelli, G Iolascon, F Gimigliano, et al.
Clinical and Experimental Rheumatology|June 7, 2011
Baseline characteristics of the population enrolled in the Italian Observational Study on Severe Osteoporosis (ISSO)S Adami, D Maugeri, V Toscano, et al.
Reumatismo|February 10, 2010
[Guidelines for the diagnosis, prevention and treatment of osteoporosis]S Adami, F Bertoldo, M L Brandi, et al.
Aging (Milan, Italy)|April 4, 2000
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study GroupT Schnitzer, H G Bone, G Crepaldi, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Controlled trial of calcitriol in the prevention of bone disease in haemodialysed patientsV L Sharman, S M Abrams, S Adami, et al.
Pageof 22